Shortening the Duration of Therapy for Staphylococcus aureus Bacteremia: Opening the Overton Window
2021; Oxford University Press; Volume: 73; Issue: 5 Linguagem: Inglês
10.1093/cid/ciab205
ISSN1537-6591
AutoresSteven Y. C. Tong, Genevieve Walls,
Tópico(s)Clostridium difficile and Clostridium perfringens research
ResumoShortening the Duration of Therapy for Staphylococcus aureus Bacteremia: Opening the Overton Window Steven Y C Tong, Steven Y C Tong Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, AustraliaDepartment of Infectious Diseases, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia Correspondence: S. Tong, The Doherty Institute, 792 Elizabeth St, Melbourne, Victoria, Australia (steven.tong@mh.org.au). https://orcid.org/0000-0002-1368-8356 Search for other works by this author on: Oxford Academic PubMed Google Scholar Genevieve Walls Genevieve Walls Department of Infectious Diseases, Middlemore Hospital, Counties Manukau Health, Auckland, New Zealand Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, Volume 73, Issue 5, 1 September 2021, Pages 873–875, https://doi.org/10.1093/cid/ciab205 Published: 02 March 2021 Article history Received: 22 February 2021 Editorial decision: 24 February 2021 Accepted: 26 February 2021 Published: 02 March 2021 Corrected and typeset: 28 April 2021
Referência(s)